iopromide has been researched along with Diffuse Lymphocytic Lymphoma, Poorly-Differentiated in 1 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baheti, AD | 1 |
| Tirumani, SH | 1 |
| Sewatkar, R | 1 |
| Sachin, SS | 1 |
| Shinagare, AB | 1 |
| Ramaiya, NH | 1 |
1 other study available for iopromide and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
| Article | Year |
|---|---|
MDCT of extranodal mantle cell lymphoma: a single institute experience.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diatrizoate Meglumine; Female; Humans; Intestines; I | 2015 |